“REVIEW OF CURRENT GUIDELINES AND STUDIES ON USE OF ACETYLSALICYLIC ACID IN THE PRIMARY CARDIOVASCULAR EVENTS PREVENTION”, Prospect. Pharm. Sci., vol. 17, no. 4, pp. 20–23, Aug. 2019, doi: 10.56782/pps.29.